or
Bookmark and Share
Oral composition and method for the treatment of inflammatory cutaneous disorders
   
Document Number
US Patent 6979468
Issued Date
December 27, 2005
Link
Inventors
Pollard; Frank (Long Grove, IL)
Map
Abstract
A method and composition for the treatment of acne vulgaris, acne rosacea, and other inflammatory skin conditions comprises the oral administration of a composition comprising a dose of nicotinamide delivered at levels substantially in excess of normal dietary levels, the nicotinamide being delivered in combination with zinc. The composition may also include quantities of copper and folic acid. In a most preferred embodiment, the nicotinamide and copper each are present in immediate release formats, while the zinc is present in a sustained release format.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
16
Comments:
no comments yet
Owner
Sirius Laboratories (Vernon Hills, IL)
Published
December 27, 2005
Application Number
10/313,165
Filed
December 6, 2002
US Classification
424/643   424/400 424/458 424/468 424/630 424/635 424/637 424/638 424/641 514/249 514/355 514/46 514/47 514/499 514/859 514/861 514/863 514/864 514/865 514/886 514/887 514/964
Int'l Classification
Examiner
Attorney/Law Firm
USPTO Field of Search
514/46   514/47   514/355   514/859   514/861   514/863   514/864   514/865   514/863   514/864   514/865   514/964   514/249   514/499   424/400   424/458   424/468   424/641   424/643   424/630   424/635   424/637   424/638  
Related Patents
7256184 - Treatment of aging disorders in humans

A method for the treatment and prophylaxis of conditions of aging in humans, such conditions of aging associated with a decreased presence of one or more cell-specific carbonic anhydrase enzymes. Such conditions include chronic neurodegenerative conditions including dementia such as Alzheimer's disease. The method comprises administering to the patient a pharmaceutically effective, non-toxic amount of a compound that increases the presence of one or more cell-specific carbonic anhydrase enzymes whose levels are reduced in the patient. Such compound may be the cell-specific carbonic anhydrase enzyme, a compound that when absorbed by the body reacts or dissociates to form the cell-specific carbonic anhydrase enzyme, or a compound that promotes the natural generation of the cell-specific carbonic anhydrase enzyme within the body.

7572937 - Process for preparing amino acids using amidocarbonylation reaction - Owned by Evonik Degussa GmbH (Essen,DE)

The present invention relates to a sequence for the preparation of amino acids, for example alpha amino acids, in particular methionine, by making use of an amidocarbonylation reaction and reuse of the catalyst.

7439390 - Process for preparing amino acids using the amidocarbonylation reaction - Owned by Degussa AG (Duesseldorf,DE)

The present invention relates to a sequence for the preparation of amino acids, for example alpha-amino acids, in particular methionine, by making use of an amidocarbonylation reaction in the presence of a cobalt carbonyl catalyst and separating the catalyst in the form of a Co(N-amino acid).sub.2 compound.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us